Crossmark

Metabolomes of mitochondrial diseases and inclusion body myositis patients: treatment targets and biomarkers

Crossref DOI link: https://doi.org/10.15252/emmm.201809091

Published Online: 2018-10-29

Published Print: 2018-12

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Buzkova, Jana

Nikkanen, Joni https://orcid.org/0000-0001-7099-4061
Ahola, Sofia

Hakonen, Anna H

Sevastianova, Ksenia

Hovinen, Topi

Yki‐Järvinen, Hannele

Pietiläinen, Kirsi H

Lönnqvist, Tuula

Velagapudi, Vidya

Carroll, Christopher J

Suomalainen, Anu https://orcid.org/0000-0003-4833-5195
Funding

Funding for this research was provided by:

European Research Council

Academy of Finland (272376)

Sigrid Juséliuksen Säätiö

Helsingin Yliopisto

Signe ja Ane Gyllenbergin Säätiö

Novo Nordisk UK Research Foundation

Jane ja Aatos Erkon Säätiö
License Information

Version of Record valid from 2018-10-29
More Information

Publication History

Received: 2018-03-05

Accepted: 2018-09-24

Published: 2018-10-29